Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
Public ClinicalTrials.gov record NCT00461396. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label, Multicenter, Observational, Phase IV Study to Evaluate the Adherence to Treatment With 250mcg (8MIU) IFNB-1b (Betaseron®) Given Subcutaneous Every Other Day Over a Period of up to 12 Months in Patients With a First Clinical Demyelinating Event Suggestive of Multiple Sclerosis and Patients With Onset of Relapsing-Remitting Multiple Sclerosis (RRMS) Within the Past 12 Months
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
* The primary aim of this study is to evaluate the impact of titration, analgesics, and 12 month telephone follow-up period from the B.E.T.A nurse program upon adherence to treatment with Betaseron in patients with a first clinical demyelinating event suggestive of Multiple Sclerosis (MS) and patients with onset of RRMS within the past 12 months * Secondary outcomes include analysis of the following parameters: progression of clinical severity by the expanded disability status scale (EDSS score), health related quality of life (HrQoL), and safety. * Exploratory outcomes include changes over time in cytokine and neurotrophic factor production by immune cells and visual function as assessed by visual examination, OCT measurements and a neuro-ophthalmologic Health-Related Quality of Life questionnaire (NEI-VFQ-25) with 10-item supplement.
Study identification
- NCT ID
- NCT00461396
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 104 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2007 (Type not available)
- Primary completion
- Jun 2009 (Actual)
- Completion
- Nov 2009 (Actual)
- Last update posted
- Apr 8, 2011
2007 – 2009
United States locations
- U.S. sites
- 19
- U.S. states
- 19
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Many Locations | Alabama | — | — |
| Not listed | Many Locations | Arizona | — | — |
| Not listed | Many Locations | Delaware | — | — |
| Not listed | Many Locations | District of Columbia | — | — |
| Not listed | Many Locations | Florida | — | — |
| Not listed | Many Locations | Georgia | — | — |
| Not listed | Many Locations | Illinois | — | — |
| Not listed | Many Locations | Iowa | — | — |
| Not listed | Many Locations | Louisiana | — | — |
| Not listed | Many Locations | Maine | — | — |
| Not listed | Many Locations | Minnesota | — | — |
| Not listed | Many Locations | Missouri | — | — |
| Not listed | Many Locations | New Jersey | — | — |
| Not listed | Many Locations | New York | — | — |
| Not listed | Many Locations | North Carolina | — | — |
| Not listed | Many Locations | Ohio | — | — |
| Not listed | Many Locations | Pennsylvania | — | — |
| Not listed | Many Locations | Tennessee | — | — |
| Not listed | Many Locations | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00461396, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2011 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00461396 live on ClinicalTrials.gov.